Pfizer Inc (NYSE:PFE) plans to provide 480 million doses of Prevenar 13 in Tanzania to control pneumococcal disease

  on Dec 07,2012 Posted in Business News ,Finance
 
Share |
We're on   

Pfizer Inc (NYSE:PFE) praises the decision of GAVI Alliance to accept the pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine {13-valent, adsorbed}), as a part of expanded pediatric immunization programme in Tanzania.

Pneumococcal disease causes vaccine-preventable deaths globally in children aging below 5 years in Tanzania.

For the debut of the this vaccine in Tanzania, representatives from GAVI Alliance will gather at a health and vaccination centre in Morogoro, outside Dar es Salaam to immunize Tanzanian child with Prevenar 13. Those representatives include the United Nations; government officials, and the country’s first lady, Salma Kikwete.

The Advance Market Commitment (AMC) played an important role in the accessibility of Prevenar 13 in Tanzania. AMC is a modern funding mechanism that supplies newer vaccines on a sustainable, affordable and accelerated basis to the world’s poorest countries.

Pfizer Inc (NYSE:PFE) intends to provide as much as 480 million doses of Prevenar 13 under the AMC to expand immunization programs for the prevention pneumococcal disease in coming 11 years.

At the close of the trading day, Pfizer Inc. (NYSE:PFE) shares rose -0.12% to settle at $25.61. Intraday trading was between $25.52 – $26.09. In the past year, the stock has traded within a range of $20.10 – $26.09. The last session’s volume of 31.46 million shares was down from the average daily trading volume of 31.80 million shares.

GlaxoSmithKline plc (ADR) (NYSE:GSK) shares were down -0.14% to close at $43.46. The stock traded between $43.25 – $43.59 during the last trading session. In the last 12 months the shares have traded between $41.68 and $47.69. The last session’s volume of 1.56 million shares was a bit lower than their average daily trading volume of 2.51 million shares.

Abbott Laboratories (NYSE:ABT) shares in the last session were up +0.06% closing at $64.58. The stock traded in a range of $64.23– $64.79. In the last year the stock has moved within a range of $53.80 – $72.47. The last session’s volume of 4.24 million shares was down from their average daily trading volume of 6.93 million shares.

Another rival company Merck & Co., Inc. (NYSE:MRK), traded up +0.27% moving to $44.51. Intraday trading recorded the stock price in a range between $44.38 – $44.59. In the previous 52 weeks the price has traded between $34.86 – $48.00. The last session’s volume of 8.82 million shares was down from their average daily trading volume of 11.55 million shares.

 



 

Leave a Reply